Dr. Dennis D. Weisenburger, MD

Dr. Weisenburger practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Weisenburger's NPI, 1699727883, was assigned on May 16, 2006. Dr. Weisenburger graduated from University Of Minnesota Medical School in 1974. Dr. Weisenburger's California license number on file is G38421.

Dr. Weisenburger's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Weisenburger also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Weisenburger's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Weisenburger to 1 more other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weisenburger practices, 2 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Weisenburger's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Weisenburger is board certified in anatomic pathology & clinical pathology by the American Board of Pathology. Dmand AI has Dr. Weisenburger's licenses on file in 3 states: California, Nebraska and Iowa.

CMS data shows 248 Medicare services from Dr. Weisenburger across 6 procedure codes in 2024, for 50 Medicare patients. Medicare paid $5,938 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Dr. Weisenburger in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weisenburger's median patient age at 62, with 0% women.

Dmand AI links 386 papers to Dr. Weisenburger, published from 2003 to 2025. 2016 was the busiest year, with 15. The most frequent topics are Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse and Antineoplastic Combined Chemotherapy Protocols. Dr. Weisenburger has published most often in Blood. Dr. Weisenburger's most frequent co-authors are Wing C. Chan, MD, Bharat Nathwani, MD and James R. Cook, MD.

Dmand AI links Dr. Weisenburger to 1 clinical trial. Conditions studied include Lymphoma, T-Cell, Peripheral and Rare Diseases.

CMS Open Payments shows 14 general payments to Dr. Weisenburger from 2 drug and device companies from 2016 to 2020. Consulting fees make up the largest share, 53% of the total. Seagen Inc. paid the most, $13,581.

Dmand AI lists 3 awards for Dr. Weisenburger, most recently America's Top Doctors in 2014.

Dr. Weisenburger graduated from University Of Minnesota Medical School in 1974.

Dr. Weisenburger is in network with 5 carriers, including United Healthcare, Aetna and CMS Medicare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.